In line with its established role in other exocrine gland cancers (i. e., breast cancer), the RANKL/RANK signaling axis elicits an aggressive salivary gland tumor phenotype both at the histologic and molecular level. This evidence concerns the gene TNFRSF11A and breast carcinoma.